These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2557047)

  • 1. Marked locomotor stimulation in monoamine-depleted mice following treatment with atropine in combination with clonidine.
    Carlsson M; Carlsson A
    J Neural Transm Park Dis Dement Sect; 1989; 1(4):317-22. PubMed ID: 2557047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dramatic synergism between MK-801 and clonidine with respect to locomotor stimulatory effect in monoamine-depleted mice.
    Carlsson M; Carlsson A
    J Neural Transm; 1989; 77(1):65-71. PubMed ID: 2545813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic interactions between muscarinic antagonists, adrenergic agonists and NMDA antagonists with respect to locomotor stimulatory effects in monoamine-depleted mice.
    Carlsson M; Svensson A; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jun; 343(6):568-73. PubMed ID: 1682816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol behaves as an NMDA antagonist with respect to locomotor stimulation in monoamine-depleted mice.
    Carlsson ML; Engberg G
    J Neural Transm Gen Sect; 1992; 87(2):155-60. PubMed ID: 1558743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.
    Devesa J; Diaz MJ; Tresguerres JA; Arce V; Lima L
    J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems.
    Carlsson M; Svensson A
    Pharmacol Biochem Behav; 1990 May; 36(1):45-50. PubMed ID: 2161545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of D-cycloserine and (+)-HA-966 on the locomotor stimulation induced by NMDA antagonists and clonidine in monoamine-depleted mice.
    Carlsson ML; Engberg G; Carlsson A
    J Neural Transm Gen Sect; 1994; 95(3):223-33. PubMed ID: 7865177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The adrenergic receptor agonist, clonidine, potentiates the anti-parkinsonian action of the selective kappa-opioid receptor agonist, enadoline, in the monoamine-depleted rat.
    Hill MP; Brotchie JM
    Br J Pharmacol; 1999 Dec; 128(7):1577-85. PubMed ID: 10602339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice.
    Rubinstein M; Schinder AF; Gershanik O; Stefano FJ
    Life Sci; 1989; 44(5):337-46. PubMed ID: 2536881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1 (but not alpha 2)-adrenoceptor agonists in combination with the dopamine D2 agonist quinpirole produce locomotor stimulation in dopamine-depleted mice.
    Eshel G; Ross SB; Kelder D; Edis LE; Jackson DM
    Pharmacol Toxicol; 1990 Aug; 67(2):123-31. PubMed ID: 1979437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice.
    Carlsson M; Svensson A
    Life Sci; 1990; 47(19):1729-36. PubMed ID: 2147454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some central effects of CGP 37849 and CGP 39551, the competitive NMDA receptor antagonists: potential antiparkinsonian activity.
    Maj J; Skuza G; Rogóz Z
    J Neural Transm Park Dis Dement Sect; 1993; 6(1):53-62. PubMed ID: 8105798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of the competitive NMDA receptor antagonist AP-5 into the nucleus accumbens of monoamine-depleted mice induces pronounced locomotor stimulation.
    Svensson A; Carlsson ML
    Neuropharmacology; 1992 May; 31(5):513-8. PubMed ID: 1356250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic alpha-adrenoceptors.
    Zebrowska-Lupina I; Przegalinski E; Sloniec M; Kleinrok Z
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):227-31. PubMed ID: 69273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat.
    Mignon L; Wolf WA
    Psychopharmacology (Berl); 2002 Aug; 163(1):85-94. PubMed ID: 12185404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice.
    Carlsson M; Carlsson A
    J Neural Transm; 1989; 75(3):221-6. PubMed ID: 2538557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effect of atropine on the adrenergic and muscarinic stimulation of phospholipid 32P labelling in isolated parotid cells: atropine, a possible blocker of alpha-adrenergic receptors.
    Imhoff V; Rossignol B
    Biol Cell; 1983; 49(1):83-6. PubMed ID: 6320938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of the caffeine-induced locomotor stimulation by a cholinergic mechanism.
    Waldeck B
    J Neural Transm; 1974; 35(3):197-205. PubMed ID: 4427109
    [No Abstract]   [Full Text] [Related]  

  • 19. Central effects of SL 82.0715, an antagonist of polyamine site of the NMDA receptor complex.
    Dereń-Wesołek A; Maj J
    Pol J Pharmacol; 1993; 45(5-6):467-80. PubMed ID: 7912135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of muscarinic cholinergic involvement in the antinociceptive effects of morphine and clonidine in the mouse.
    Lipman JJ; Spencer PS
    Eur J Pharmacol; 1980 Jun; 64(4):249-58. PubMed ID: 7389822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.